Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients

• Controlling age and sex, NLR>6.5 increases the chance of disease severity by 4 times. • NLR>6.5 increases the chance of death about 1.8 times after age and sex adjustments. • The average value of WBC among severe patients was higher than non-severe.

Detalles Bibliográficos
Autores principales: Haghjooy Javanmard, Shaghayegh, Vaseghi, Golnaz, Manteghinejad, Amirreza, Nasirian, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428697/
https://www.ncbi.nlm.nih.gov/pubmed/32810639
http://dx.doi.org/10.1016/j.jgar.2020.07.029
_version_ 1783571132506439680
author Haghjooy Javanmard, Shaghayegh
Vaseghi, Golnaz
Manteghinejad, Amirreza
Nasirian, Maryam
author_facet Haghjooy Javanmard, Shaghayegh
Vaseghi, Golnaz
Manteghinejad, Amirreza
Nasirian, Maryam
author_sort Haghjooy Javanmard, Shaghayegh
collection PubMed
description • Controlling age and sex, NLR>6.5 increases the chance of disease severity by 4 times. • NLR>6.5 increases the chance of death about 1.8 times after age and sex adjustments. • The average value of WBC among severe patients was higher than non-severe.
format Online
Article
Text
id pubmed-7428697
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
record_format MEDLINE/PubMed
spelling pubmed-74286972020-08-17 Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients Haghjooy Javanmard, Shaghayegh Vaseghi, Golnaz Manteghinejad, Amirreza Nasirian, Maryam J Glob Antimicrob Resist Short Communication • Controlling age and sex, NLR>6.5 increases the chance of disease severity by 4 times. • NLR>6.5 increases the chance of death about 1.8 times after age and sex adjustments. • The average value of WBC among severe patients was higher than non-severe. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2020-09 2020-08-15 /pmc/articles/PMC7428697/ /pubmed/32810639 http://dx.doi.org/10.1016/j.jgar.2020.07.029 Text en © 2020 Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Haghjooy Javanmard, Shaghayegh
Vaseghi, Golnaz
Manteghinejad, Amirreza
Nasirian, Maryam
Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
title Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
title_full Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
title_fullStr Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
title_full_unstemmed Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
title_short Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
title_sort neutrophil-to-lymphocyte ratio as a potential biomarker for disease severity in covid-19 patients
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428697/
https://www.ncbi.nlm.nih.gov/pubmed/32810639
http://dx.doi.org/10.1016/j.jgar.2020.07.029
work_keys_str_mv AT haghjooyjavanmardshaghayegh neutrophiltolymphocyteratioasapotentialbiomarkerfordiseaseseverityincovid19patients
AT vaseghigolnaz neutrophiltolymphocyteratioasapotentialbiomarkerfordiseaseseverityincovid19patients
AT manteghinejadamirreza neutrophiltolymphocyteratioasapotentialbiomarkerfordiseaseseverityincovid19patients
AT nasirianmaryam neutrophiltolymphocyteratioasapotentialbiomarkerfordiseaseseverityincovid19patients

Ejemplares similares